Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
62.6M
Number of holders
46
Total 13F shares, excl. options
14.6M
Shares change
+10.9M
Total reported value, excl. options
$14.7M
Value change
+$11M
Put/Call ratio
0.07
Number of buys
21
Number of sells
-18
Price
$0.98

Significant Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q1 2025

58 filings reported holding IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2025.
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.6M shares of 62.6M outstanding shares and own 23.27% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (4.33M shares), Nantahala Capital Management, LLC (3.16M shares), Opaleye Management Inc. (1.18M shares), BIOS Capital Management, LP (995K shares), VANGUARD GROUP INC (992K shares), Mink Brook Asset Management LLC (810K shares), Bleichroeder LP (737K shares), AWM Investment Company, Inc. (524K shares), GEODE CAPITAL MANAGEMENT, LLC (353K shares), and ROYAL BANK OF CANADA (304K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.